This video highlights a new study that found that markers of immune response in prostate cancer may be able to predict patients’ response to radiation therapy, likelihood of recurrence, and survival.
Shuang George Zhao, MD, MSE
Advertisement
Articles by Shuang George Zhao, MD, MSE
Advertisement
Latest Updated Articles
ASTRO 2017: Immune Markers in Prostate Cancer Predict RT ResponsePublished: October 4th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
2
Frontline Alectinib Upholds OS Benefit in Advanced ALK+ NSCLC
3
Tarlatamab Improves Survival Vs Chemotherapy in Second-Line SCLC Subgroups
4
Episode 16: Anticipated ESMO 2025 Data That May Change GU Oncology
5
